Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, absolute, Affymax, Agha, AHGD, antihypertensive, appl, Arqule, Astex, Austria, Aveo, Basel, BCF, Belgium, BioReliance, blockbuster, Boehringer, Bone, Bristol, British, Buchholz, budgetary, CDRSA, Cleveland, COBRA, contributor, Cozaar, Danish, Darmstadt, David, Delaware, denied, deployment, deviation, disadvantage, disciplined, dismissed, disputed, docketing, Dodd, empower, envelope, Ergomed, Erlangen, Exelon, exploratory, FCPA, fell, Fosamax, Fulbright, Galena, Gallagher, Georgia, GlyPharma, Harvard, Helix, hinder, host, hundred, inflationary, infrastructure, Ingelheim, intramuscular, Isoray, JP, Jude, Karger, Leader, MACRILEN, Maxalt, Maxigen, Mead, medium, merge, Merrimack, Millipore, mixture, MSA, Navigant, Neurosurgery, NGC, Obama, offeror, outsource, overhaul, oversaw, pat, Patch, PDUFA, peer, Peregrine, persuade, Pharmathene, physical, Popovic, prejudice, Prolia, PROREIT, PTA, Puerto, Pyridopyrazine, ramping, realign, Reda, Repligen, reposition, representation, resignation, Rico, Sachse, Salzburg, scientist, serial, Singulair, southeastern, Stefan, superseded, Targacept, Tekturna, therefrom, timeline, transformation, TSA, UCB, underwritten, unilaterally, Unimed, unnecessarily, USC, User, Verastem, Vical, Vioxx, visualized, Vytorin, warehousing, whichever, wholly, won, ZoptEC
Removed:
Acadia, acetate, acid, Andrew, AON, Arcoda, Array, assisted, avoided, banking, Beecham, Biochemistry, BioMedica, biomedical, BioSant, Blaikie, blocked, bortezomib, BS, capecitabine, carcinoma, castrating, cautioned, Cephalon, cetrorelix, chronic, Chugai, CMC, companion, comparatively, Conversely, device, dexamethasone, diagnosed, distribute, East, Educational, egg, ElexoPharm, endocrine, enrolment, Enzon, equimolar, estimable, estimating, fifty, foreseen, founding, ganirelix, Genomic, GIG, gradually, GSK, Hambrecht, Heenan, hormonal, hyperstimulation, importance, inherited, initiate, injectable, injection, internally, Internet, Isotechnika, Keryx, launched, Laureate, Leiden, LH, lieu, Ligand, London, LP, Lynch, lyophilizate, lyophilization, margin, marked, maturation, Merrill, Mount, naturally, Neurocrine, neurotoxicology, Nobel, Nps, obstructive, omitted, onset, Onyx, optionee, organic, outlook, ovulation, Oxford, pancreatic, pharmaceutically, pharmacologic, Plough, Polytechnic, premature, presently, prospective, pulmonary, Quist, recoup, recovery, redesignated, regained, relapsed, releasing, remit, reproductive, retrieve, revision, Roche, Royal, San, Schally, Schering, seasoned, Seeber, sexual, short, Sinai, sleep, slightly, SmithKline, solution, South, spent, St, sterile, stimulating, strive, surge, suspended, Switzerland, syndrome, twenty, UK, undergo, undergoing, undue, update, variation, Velcade, Xeloda, Xoma, Zurich
Filing tables
Filing exhibits
AEZS similar filings
Filing view
External links
Exhibit 4.3
![](https://capedge.com/proxy/20-F/0001113423-14-000004/aeternazentariscouleur.jpg)
1405 boul du Parc Technologique Quebec (Quebec) G1P 4P5 Canada | 100 Marketplace, Suite 203 25 Mountainview Blvd. Basking Ridge, NJ 07920-3452 USA |
June 14, 2013
DELIVERED BY HAND
Paul Blake, M.D.
Senior Vice President and Chief Medical Officer
[civic address redacted for privacy reasons]
Re: Termination of the Change of Control Program
Dear Paul:
As provided in your employment agreement, Aeterna Zentaris Inc. (hereinafter the "Corporation") hereby formally informs you that the Change of Control Program (hereinafter the "Program") that is currently detailed in Appendix 1 of your employment agreement is terminated.
Section 5 of Appendix 1 of your employment agreement dated July 18, 2007 provides that the Corporation may terminate the Program at any time and for any reason by providing you with a written notice of at least 30 days prior to each anniversary date of the signature of the agreement, namely July 18.
The Corporation has decided to exercise its right to terminate the Program.
As a consequence of the termination of the Program, section 7.1 and Appendix 1 of your employment agreement shall be deemed void and inapplicable as of July 18, 2013, although the termination of the Program does not affect the remaining provisions of your employment agreement.
Please let me know if you have any questions related to the above.
Sincerely,
![](https://capedge.com/proxy/20-F/0001113423-14-000004/signaturedaviddodd.jpg)
David A. Dodd
President and CEO